Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease
This study has been completed.
Study NCT00005578 Information provided by National Cancer Institute (NCI)
First Received: May 2, 2000 Last Updated: July 11, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cardiac Toxicity
Lymphoma
Additional conditions recognized in this trial
Hodgkin Disease
More general conditions related to this trial
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Interventions listed in this trial
bleomycin sulfate
filgrastim
cyclophosphamide
dexrazoxane hydrochloride
doxorubicin hydrochloride
etoposide
prednisone
vincristine sulfate
radiation therapy
Additional drug interventions recognized in this trial
Bleomycin
Doxorubicin
Razoxane
Vincristine
More general drug interventions related to this trial
Alkylating Agents
Anti-Inflammatory Agents
Antibiotics, Antineoplastic
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Alkylating
Antineoplastic Agents, Hormonal
Antineoplastic Agents, Phytogenic
Antirheumatic Agents
Cardiovascular Agents
Chelating Agents
Glucocorticoids
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Immunologic Factors
Immunosuppressive Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Myeloablative Agonists
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
Children's Oncology Group
National Cancer Institute (NCI)
Back to top of Main Content
